| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2f46034fd34ef3d1821c728590e4cb4e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8c3ebac9567cfaa4b9de5a326a89c06b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b252075569e1d4ea4e31ae88fc43704f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_88d727cf4f756e56b14db1a963bf0911
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2258060ecdd9b1fa0e29e8b6b77fa2f7 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57415 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12M1-00 |
| filingDate |
2009-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d8fa3ab0b43b4ba19a4e730a6b6b15d4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f06a9d82e9e02542ca4ee64a9e764521
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2949f33e497ddc0c17356caad4d10db7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bfe3ccaef53c1d3fd06261946bae5f64 |
| publicationDate |
2010-06-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2010067722-A1 |
| titleOfInvention |
Method for evaluating degree of malignancy of breast cancer, and kit for the evaluation |
| abstract |
Disclosed are: a method for evaluating the degree of malignancy of breast cancer, which is simple and rapid and has high reliability; and an array and a kit for use in the evaluation method. Specifically disclosed are: a method for evaluating the degree of malignancy of breast cancer based on the expression patterns of at least three genes selected from a group consisting of BMP7, CD24, CD44, CXCL12, PIK3R1 and SOCS2 in a test sample, wherein the expression patterns are determined based on the expression levels of the at least three genes; an array for the above-mentioned evaluation, which comprises a support and nucleic acids corresponding to the at least three genes and/or fragments of the nucleic acids immobilized on a predetermined area on the support; a kit for the above-mentioned evaluation, which can detect mRNA molecules expressed from the at least three genes and/or fragments of the mRNA molecules; and a kit for the above-mentioned evaluation, which comprises antibodies directed against polypeptides encoded by the at least three genes and/or fragments of the polypeptides and/or fragments of the antibodies. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2013133220-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013133220-A1 |
| priorityDate |
2008-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |